BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20442710)

  • 1. FimH can directly activate human and murine natural killer cells via TLR4.
    Mian MF; Lauzon NM; Andrews DW; Lichty BD; Ashkar AA
    Mol Ther; 2010 Jul; 18(7):1379-88. PubMed ID: 20442710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.
    Ashkar AA; Mossman KL; Coombes BK; Gyles CL; Mackenzie R
    PLoS Pathog; 2008 Dec; 4(12):e1000233. PubMed ID: 19057665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.
    Mossman KL; Mian MF; Lauzon NM; Gyles CL; Lichty B; Mackenzie R; Gill N; Ashkar AA
    J Immunol; 2008 Nov; 181(10):6702-6. PubMed ID: 18981086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
    Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
    Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FimH as a mucosal adjuvant enhances persistent antibody response and protective efficacy of the anti-caries vaccine.
    Liu ZF; Chen JL; Li WY; Fan MW; Li YH
    Arch Oral Biol; 2019 May; 101():122-129. PubMed ID: 30927661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Uchiya KI; Kamimura Y; Jusakon A; Nikai T
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30602501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9.
    De Pascalis R; Rossi AP; Mittereder L; Takeda K; Akue A; Kurtz SL; Elkins KL
    PLoS One; 2020; 15(8):e0237034. PubMed ID: 32745117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
    Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
    J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of natural killer activity and IFN-γ production in an IL-12-dependent manner by a Brassica rapa L.
    Yamamoto K; Furuya K; Yamada K; Takahashi F; Hamajima C; Tanaka S
    Biosci Biotechnol Biochem; 2018 Apr; 82(4):654-668. PubMed ID: 29207919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens.
    Asadi Karam MR; Habibi M; Bouzari S
    Biologicals; 2016 Sep; 44(5):378-86. PubMed ID: 27461240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy.
    Zhang W; Xu L; Park HB; Hwang J; Kwak M; Lee PCW; Liang G; Zhang X; Xu J; Jin JO
    Nat Commun; 2020 Mar; 11(1):1187. PubMed ID: 32132528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.
    Chalifour A; Jeannin P; Gauchat JF; Blaecke A; Malissard M; N'Guyen T; Thieblemont N; Delneste Y
    Blood; 2004 Sep; 104(6):1778-83. PubMed ID: 15166032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine decreases the function of primary human natural killer cells by both TLR4 and opioid receptor signaling.
    Maher DP; Walia D; Heller NM
    Brain Behav Immun; 2020 Jan; 83():298-302. PubMed ID: 31626971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.
    Zughaier SM; Zimmer SM; Datta A; Carlson RW; Stephens DS
    Infect Immun; 2005 May; 73(5):2940-50. PubMed ID: 15845500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.
    Mestre-Durán C; Martín-Cortázar C; García-Solís B; Pernas A; Pertíñez L; Galán V; Sisinni L; Clares-Villa L; Navarro-Zapata A; Al-Akioui K; Escudero A; Ferreras C; Pérez-Martínez A
    Front Immunol; 2022; 13():1045316. PubMed ID: 36685552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo.
    Delale T; Paquin A; Asselin-Paturel C; Dalod M; Brizard G; Bates EE; Kastner P; Chan S; Akira S; Vicari A; Biron CA; Trinchieri G; Brière F
    J Immunol; 2005 Nov; 175(10):6723-32. PubMed ID: 16272328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.